Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gery Tomassoni

Clinical Cardiac Electrophysiology Lexington, KY Medical Doctor

NPI 1114956802 CMS profile 186481

1720 Nicholasville Rd, Suite 601, Lexington, KY 40503

Open in the dashboard

General payments

$196,022

970 records reported · program years 2019–2025

Research payments

$15,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,956,122 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Gery Tomassoni of Lexington, KY is reported in the CMS Open Payments database as having received $196,022 across 970 general payments and $15,500 in research payments paid to them. Separately, studies naming them as principal investigator received $1,956,122 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $50,039 186
2025 Research $15,500 1
2024 General $30,236 157
2023 General $23,697 106
2022 General $19,786 134
2021 General $22,205 120
2020 General $12,421 86
2019 General $37,639 181

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gery Tomassoni
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Gery Tomassoni were reported at $50,039. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Gery Tomassoni Clinical Cardiac Electrophysiology median Middle half National median
2019 $37,639 $2,361 $585–$8,260 $163
2020 $12,421 $993 $247–$4,351 $114
2021 $22,205 $1,185 $326–$4,739 $132
2022 $19,786 $2,073 $554–$6,789 $149
2023 $23,697 $2,568 $759–$8,159 $160
2024 $30,236 $2,557 $703–$7,403 $164
2025 $50,039 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $32,291 263 payments
  2. Impulse Dynamics (USA) Inc. $31,139 45 payments
  3. Atricure, Inc. $26,990 48 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $22,453 99 payments
  5. Abbott Laboratories $22,255 125 payments
  6. Vektor Medical Inc. $15,370 5 payments
  7. Cardiva Medical, Inc. $10,990 13 payments
  8. Acutus Medical, Inc. $9,689 23 payments
  9. Biosense Webster, Inc. $6,740 40 payments
  10. Medtronic Vascular, Inc. $4,977 19 payments
  11. Other $13,129 290 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $91,955 38 payments
  2. Travel and Lodging $38,588 123 payments
  3. Food and Beverage $31,641 775 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,550 11 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $9,938 11 payments
  6. Honoraria $6,000 2 payments
  7. Entertainment $350 10 payments
Products named General payments · program years 2019–2025
  1. LifeVest $22,453 99 payments
  2. vMap $12,120 2 payments
  3. Optimizer Smart System Cardiovascular Device $11,749 15 payments
  4. OPTIMIZER SMART SYSTEM Cardiovascular Device $9,950 2 payments
  5. FARAPULSE $6,680 15 payments
  6. General Therapies $6,337 13 payments
  7. Gallant CRT-D $5,974 9 payments
  8. OPTIMIZER Cardiovascular Device $5,443 20 payments
  9. OPTIMIZER Cardiovascular Device $5,443 20 payments
  10. CARDIOMEMS $5,047 17 payments
  11. Other $72,057 767 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Vektor Medical Inc. $15,500 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 47 drugs

Part D claims

4,293

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$1,313,289

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

39.2%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 814 $753,472
Xarelto Rivaroxaban Brand 216 $269,533
Entresto Sacubitril/Valsartan Brand 157 $146,149
Dofetilide Generic 291 $36,551
Multaq Dronedarone Hcl Brand 21 $26,005
Jardiance Empagliflozin Brand 18 $22,003
Flecainide Acetate Generic 443 $21,071
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 130 $4,435
Propafenone Hcl Er Propafenone Hcl Brand 19 $3,255
Metoprolol Succinate Generic 213 $2,978

The 10 drugs with the highest cost, of 47 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 77 billing codes

Paid by Medicare

$225,696

Medicare's payments for the services billed

Medicare patients

773

Average age 76

Services billed

4,275

326 women, 447 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 49%
Heart failure 48%
Arthritis 48%
Diabetes 34%
Chronic kidney disease 32%
COPD 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 11 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BRILINTA
$37 — —
VYNDAQEL
$29 — —
Arcalyst
$25 — —
CAMZYOS
$21 — —
ELIQUIS
$20 814 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 11 in the dashboard with a free account

Records

971 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record